Patent intelligence · US
US 11447500
Thienopyridine derivatives and pharmaceutical composition comprising same
Thienopyridine derivatives and pharmaceutical composition comprising same
Patent details — US 11447500
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 20, 2022
- Expiration
- Sep 15, 2042
- Applicant
- Wellmarker Bio Co., LTD.
- Claims
- 15
- CPC classes
- A61P, A61P35/00
Quick answer
US 11447500 (Thienopyridine derivatives and pharmaceutical composition comprising same) is held by Wellmarker Bio Co., LTD.. Status: granted. Granted Sep 20, 2022. Expires Sep 15, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Wellmarker Bio Co., LTD.
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61P, A61P35/00
More from Wellmarker Bio Co., LTD.
Related pharmaceutical patents in our USPTO index.
-
US 12077601
Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods
granted -
US 11885817
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 11692030
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 11598782
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 11186873
Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)
granted -
US 11078298
Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods
granted -
US 11008622
Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof
granted
Frequently asked questions
What is US patent 11447500?
US 11447500 (Thienopyridine derivatives and pharmaceutical composition comprising same) is held by Wellmarker Bio Co., LTD.. Status: granted. Granted Sep 20, 2022. Expires Sep 15, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11447500?
Wellmarker Bio Co., LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 27 pharmaceutical patents for this assignee.
When does US 11447500 expire?
Our index shows an expiration date of Sep 15, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.